Loading
B&
Body & Mind Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Bengal Impact Partners, LLC, was filed 17 May 2023.
Body & Mind Inc.: what insiders have been doing
Body & Mind Inc., classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Body & Mind Inc. has published a filing in the past twelve months. The most recent one dates from 14 February 2024.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
57
Thresholds
n/a
Buy Volume
€76,245
7 ops. · all time
Sell Volume
€2M
48 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended July 2023 · cache
Income statement
Gross profitUS$5M
Net income-US$17.7M
Last declaration on 14 February 2024
Declarations57 total
2,700,393 shares@ US$0.066786.0% of flowCommon SharesSEC:0001104659-24-023153:0
671,642 shares@ US$0.044514.0% of flowCommon SharesSEC:0001104659-23-062011:0
Canonical exit: 6 Aug 2023 (T+90)
20,000 shares@ US$0.1521.4% of flowCommon StockSEC:0001183740-22-000105:0
Canonical exit: 2 Aug 2022 (T+90)
109,000 shares@ US$0.2477.7% of flowCommon StockSEC:0001183740-22-000071:0
Canonical exit: 20 Jun 2022 (T+90)
25,000 shares@ US$0.2541.8% of flowCommon StockSEC:0001183740-22-000028:0
Canonical exit: 4 May 2022 (T+90)
16,667 shares@ US$0.36100.0% of flowCommon StockSEC:0001183740-22-000010:0
Canonical exit: 11 Apr 2022 (T+90)
20,000 shares@ US$0.38522.3% of flowCommon StockSEC:0001183740-21-000322:0
Canonical exit: 23 Mar 2022 (T+90)
20,000 shares@ US$0.27536.8% of flowCommon StockSEC:0001183740-21-000321:0
Canonical exit: 22 Mar 2022 (T+90)
5,900,000 shares@ US$0.237148.5% of flowCommon StockSEC:0001183740-21-000236:0
4,000,000 shares@ US$0.236533.2% of flowCommon StockSEC:0001183740-21-000225:0
8,000 shares@ US$0.35540.1% of flowCommon StockSEC:0001183740-21-000219:0
18,000 shares@ US$0.36070.2% of flowCommon StockSEC:0001183740-21-000217:0
3,500 shares@ US$0.34120.0% of flowCommon StockSEC:0001183740-21-000213:0
15,500 shares@ US$0.35730.2% of flowCommon StockSEC:0001183740-21-000218:0
6,500 shares@ US$0.35470.1% of flowCommon StockSEC:0001183740-21-000220:0
20,500 shares@ US$0.36550.3% of flowCommon StockSEC:0001183740-21-000215:0
15,000 shares@ US$0.35350.2% of flowCommon StockSEC:0001183740-21-000214:0
17,000 shares@ US$0.35690.2% of flowCommon StockSEC:0001183740-21-000216:0
5,500 shares@ US$0.32780.1% of flowCommon StockSEC:0001183740-21-000209:0
13,000 shares@ US$0.33780.2% of flowCommon StockSEC:0001183740-21-000207:0
2,500 shares@ US$0.34970.0% of flowCommon StockSEC:0001183740-21-000205:0
500 shares@ US$0.36050.0% of flowCommon StockSEC:0001183740-21-000206:0
14,000 shares@ US$0.33470.2% of flowCommon StockSEC:0001183740-21-000208:0
14,000 shares@ US$0.35980.2% of flowCommon StockSEC:0001183740-21-000195:0
31,000 shares@ US$0.35790.4% of flowCommon StockSEC:0001183740-21-000190:0
25 of 57 declarations
About Body & Mind Inc.
Body and Mind Inc. (ticker BAMM) is a United States cannabis operator with investor communications aimed at North American capital markets. For the purpose of this brief, it should be viewed as a health-and-wellness adjacent equity within the broader U.S. listed universe, with investor attention often centered on insider activity disclosures and corporate events relevant to the NASDAQ/NYSE ecosystem. The company was originally formed as Deploy Technologies, then renamed Body and Mind Inc. after it completed the acquisition of Nevada Medical Group in November 2017. Since then, it has pursued a multi-state cannabis model combining cultivation, processing, and retail. Its operational footprint is associated with Las Vegas, Nevada, while its corporate history also includes Vancouver, underscoring its cross-border origins.\n\nBody and Mind builds and markets cannabis products under its BaM brand and, depending on local licenses and market conditions, operates dispensaries and production assets across selected U.S. states. Its product mix includes flower, pre-rolls, concentrates, vape cartridges, and edibles, with an emphasis on craft-oriented production, state-compliant testing, and brand consistency. The company is best described as a niche operator rather than a national scale leader. Its competitive position stems from operational know-how in limited-license jurisdictions, selective brand building, and a geographically diversified footprint rather than from sheer volume or market share dominance.\n\nGeographically, Body and Mind has historically maintained operations or projects in California, Nevada, Ohio, Arkansas, Michigan, as well as assets or initiatives linked to Illinois and New Jersey. This footprint reflects a state-by-state strategy aimed at capturing growth in regulated cannabis markets with different consumer profiles and licensing regimes. Recent developments have included continued portfolio optimization and asset transactions in 2025, including moves tied to dispensary and state-level operations. For French-speaking investors, BAMM is therefore a special-situations micro-cap cannabis name: attractive for its operating optionality, but also exposed to regulatory risk, local licensing constraints, balance-sheet sensitivity, and the liquidity profile typical of smaller U.S. listed names.
